By: Kashif Hussain, Senior Media Professional
A half-truth does not always require a false statement. Sometimes, all it requires is half the evidence.
In the digital age, journalism is under constant pressure to attract attention. A dramatic headline travels faster than a carefully qualified explanation. A statistic can be accurate but misleading without its baseline. A quote can be genuine but distorted when stripped of context. A scientific finding can be correctly reported while its limitations are left behind. This is where responsible journalism matters most.
Health and science reporting are particularly vulnerable to this problem. There is a significant difference between saying that researchers found an association and saying that one thing causes another. Understanding that difference requires looking beyond the headline: Who was studied? What was their existing health history? What other risk factors were present? Was the research observational or experimental? And what limitations did the researchers themselves identify? The debate around smoking, vaping and tobacco harm reduction provides a good example.
A few months ago, social media was flooded with claims suggesting that vaping could cause people to lose their eyesight. The headlines and short videos were alarming, but the underlying evidence required considerably more attention. When research involves people who have transitioned from smoking to vaping, their history matters. A person who has spent years smoking may already have accumulated significant health risks, and switching to vaping does not reverse damage that may have already occurred. Vaping is not a treatment for existing eye disease. At the same time, this does not mean that vaping should automatically be described as harmless.
Studies have reported changes in retinal microcirculation among e-cigarette users, including differences in retinal vessel density and the foveal avascular zone. However, other research has found no significant differences in several retinal structural parameters. The evidence therefore warrants further investigation; it does not support the simplistic claim that vaping causes blindness, nor does it justify describing vaping as risk-free. That nuance is precisely what responsible journalism should preserve.
Tobacco harm reduction is based on a relatively simple principle: not all nicotine products expose users to the same substances or risks. Combustible cigarettes burn tobacco and generate thousands of chemicals, including many toxic substances. Non-combustible alternatives remove combustion, but they do not remove all risk. The relevant question for adult smokers who cannot or will not quit is therefore not simply whether a product is “safe.” It is whether switching completely from cigarettes to a non-combustible alternative can reduce exposure to harmful substances compared with continuing to smoke.
That is a question of relative risk, not an argument for calling any nicotine product harmless.
There is also an important distinction between someone who has never smoked and an adult smoker looking for an alternative. A non-smoker does not need a nicotine product. For an existing smoker, however, the public-health conversation may involve cessation, nicotine replacement, or potentially less harmful alternatives. Treating all these situations as identical produces poor journalism and poor public-health communication.
This does not mean journalists should become advocates for vaping or any other product. Quite the opposite. The journalist’s responsibility is to examine the evidence critically, including evidence that challenges the preferred narrative.
If a study finds a possible health risk, report it. If the evidence is limited, say so. If participants had significant pre-existing risk factors, mention them. If a study establishes correlation rather than causation, do not turn it into causation through a headline.
The same standard should apply in the opposite direction. Evidence suggesting that a non-combustible product may carry lower risks than cigarettes should not be presented as proof that the product is safe. The public deserves neither promotion nor fear disguised as journalism. It deserves context.
Before sharing the next alarming health claim, perhaps the most important question is also the simplest: What does the actual evidence say beyond the headline? Because accuracy is not merely about publishing facts that are technically true. It is about giving people enough of the truth to understand what those facts actually mean.